Intervention Protocol

Interferon beta for chronic hepatitis B

  1. Nazir Ibrahim1,*,
  2. Mohammed Eyad Yaseen AlSabbagh2,
  3. Mohammed Qintar2,
  4. Mouhanad Samra3,
  5. Yasser Shahrour2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 MAY 2010

Assessed as up-to-date: 28 FEB 2010

DOI: 10.1002/14651858.CD003622.pub2

How to Cite

Ibrahim N, Yaseen AlSabbagh ME, Qintar M, Samra M, Shahrour Y. Interferon beta for chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No.: CD003622. DOI: 10.1002/14651858.CD003622.pub2.

Author Information

  1. 1

    Alkalamon University, Damascus, Syrian Arab Republic

  2. 2

    Damascus University-Medical College, Damascus, Syrian Arab Republic

  3. 3

    Medicine, Damascus, Syrian Arab Republic

*Nazir Ibrahim, Alkalamon University, PO Box 4018, Damascus, Syrian Arab Republic.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 12 MAY 2010




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the beneficial and harmful effects of interferon beta for patients with chronic hepatitis B.